共 19 条
[1]
Adams A.R.D., Waters M.F.R., Dapsone‐resistant lepromatous leprosy in England, British Medical Journal, 11, (1966)
[2]
Barranco V.P., Minor D.B., Solomon H., Treatment of relapsing polychondritis with dapsone, Archives of Dermatology, 112, pp. 1286-1288, (1976)
[3]
Barranco V.P., Inhibition of lysosomal enzymes by dapsone, Archives of Dermatology, 110, pp. 563-566, (1974)
[4]
Gelber R.H., Levy L., The effect of dihydrofolate reductase inhibitors on Mycobacterium leprae in the mouse foot‐pad, International Journal of Leprosy, 44, pp. 124-132, (1976)
[5]
Faget G.H., Pogge R.C., Johansen F.A., Dinan J.F., Prejean B.M., Eccles C.G., The Promin treatment of leprosy. A progress report, Public Health Reports (1896-1970), 58, pp. 1729-1741, (1943)
[6]
Martin J., Roenigk H.H., Lynch W., Tingwald F.R., Relapsing polychondritis treated with dapsone, Archives of Dermatology, 112, pp. 1272-1274, (1976)
[7]
McCullough J.L., Maren T.H., Inhibition of dihydropteroate synthetase from Escherichia Coli by sulfones and sulfonamides, Antimicrobial Agents and Chemotherapy, 3, pp. 665-669, (1973)
[8]
Mier P.D., Cotton D.W.K., The Molecular Biology of Skin, (1976)
[9]
Millikan L.E., Conway F.R., Effect of drugs on the Pillemer pathway‐dapsone, Journal of Investigative Dermatology, 62, (1974)
[10]
Morrison N.E., Sequential blockade of the mycobacterial De Novo folate pathway, International Journal of Leprosy, 39, pp. 34-43, (1971)